
Patrick Dallemagne
104
Documents
Publications
Publications
Drug library screening for putative antiviral compounds'discovery against equine arteritis virus12th International Equine Infectious Diseases Conference, EIDC, Sep 2024, Deauville, France. pp.56-57 (n°83), ⟨10.1111/evj.14298⟩
Communication dans un congrès
hal-04723725
v1
|
|
Tick-Borne Encephalitis Virus-infected human neuronal/glial cells identify antiviral drugs10th European Meeting of Viral Zoonoses, Sep 2023, Saint-Raphaël, France
Communication dans un congrès
hal-04509311
v1
|
|
Tick-Borne Encephalitis Virus-infected human neuronal/glial cells identify antiviral drugsXXVèmes Journées Francophones de Virologie, Société Française de Virologie, Apr 2023, Paris, France
Communication dans un congrès
hal-04481153
v1
|
|
Tick-Borne Encephalitis Virus-infected human neuronal/glial cells identify antiviral drugs36th International Conference on Antiviral Research, International Society for Antiviral Research (ISAR), Mar 2023, Lyon, France
Communication dans un congrès
hal-04481101
v1
|
|
La réplication du virus de l'artérite équine est efficacement supprimée par les inhibiteurs de la biosynthèse des purines et des pyrimidinesJournées scientifiques et doctorales de l'Anses (JSDA), Anses, Oct 2022, Maisons-Alfort, France
Communication dans un congrès
anses-04571182
v1
|
|
Tick-Borne Encephalitis Virus-infected human neuronal/glial cells identify antiviral drugsJournées Scientifiques et Doctorales de l'ANSES (JSDA), ANSES, Oct 2022, Maisons-Alfort, France
Communication dans un congrès
hal-04481141
v1
|
|
Two- and three-dimensional in vitro models for investigating TBEV-induced neuropathogenesis and discovering therapeutic drugsJournées "Tiques et Maladies à Tiques", Groupe "Tiques et Maladies à Tiques" (TMT), Mar 2022, Nancy, France
Communication dans un congrès
hal-04481097
v1
|
|
Tick-Borne Encephalitis Virus-infected human neuronal/glial cells identify antiviral drugsJournées d’Animation Scientifiques du Département de Santé Animale, INRAE (Département de Santé Animale), Oct 2022, Aglet, France
Communication dans un congrès
hal-04481147
v1
|
|
|
Identification of antiviral compounds against equid herpesvirus‐1 using Real‐Time Cell Analysis: screening of 2,891 molecules11th International Equine Infectious Diseases Conference, Sep 2021, Online, France. ⟨10.1111/evj.83_13495⟩
Communication dans un congrès
hal-03405801
v1
|
|
Development of a high‐throughput screening assay to identify equine virus arteritis replication inhibitors11th International Equine Infectious Diseases Conference, EIDC, Sep 2021, Online, France. pp.63-64, ⟨10.1111/evj.95_13495⟩
Communication dans un congrès
hal-03374819
v1
|
|
Un nouvel arsenal thérapeutique contre la rhinopneumonie équineJournées sciences et innovations équines 2020, Nov 2020, Le Pin au Haras, France
Communication dans un congrès
hal-03219395
v1
|
Development of a high- throughput cell-based assay to determine anti-equine arteritis virus properties of chemical compounds10th international equine infectious disease congress, EIDC, Apr 2016, Buenos Aires, Argentina
Communication dans un congrès
hal-02953721
v1
|
Identification & characterization of a new series of CHK1 inhibitorsAxe 2 Workshop - Genome dynamics and expression, Sep 2024, Toulouse, France
Poster de conférence
hal-04930178
v1
|
|
Antiviral strategies in equines12th International Equine Infectious Diseases Conference, Sep 2024, Deauville, France. Equine Vetenary Journal, 56 (Suppl. 60), pp.97-98 (n°159), ⟨10.1111/evj.14215⟩
Poster de conférence
hal-04724269
v1
|
|
Identification & characterization of a new series of CHK1 inhibitorsDNA replication and replication stress, Dec 2024, Montpellier, France
Poster de conférence
hal-04930209
v1
|
|
Pharmacokinetic and safety of a novel pleiotropic compound in C57BL/6J mice with potential therapeutic interest in Alzheimer’s diseaseFENS 2024, Jun 2024, Vienne, Austria
Poster de conférence
hal-04632974
v1
|
|
Modeling SARS-COV2-infected central nervous system using human neuronal/glial cells to identify antiviral drugs36th International Conference on Antiviral Research, Mar 2023, Lyon, France
Poster de conférence
hal-04481047
v1
|
|
Tick-Borne Encephalitis Virus-infected human neuronal/glial cells identify antiviral drugs36th International Conference on Antiviral Research, Mar 2023, Lyon, France
Poster de conférence
hal-04480802
v1
|
|
Modeling SARS-COV2-infected central nervous system using human neuronal/glial cells to identify antiviral drugsNouvelles stratégies antivirales : de la recherche à clinique - New antiviral strategies: form bench to bedside., Apr 2023, Paris, France
Poster de conférence
hal-04481120
v1
|
|
Modeling SARS-COV2-infected central nervous system using human neuronal-glial cells to identify antirviral drugsXXVèmes Journées Francophones de Virologie, Apr 2023, Paris, France
Poster de conférence
hal-04481111
v1
|
|
Identification and validation of a novel DDR inhibitor provides novel insights into the mechanisms of resistance to Chk1 inhibitors14th edition of the French 3R meeting, May 2022, Presqu'ile de Giens, France
Poster de conférence
hal-04931033
v1
|
|
Identification and validation of a novel DDR inhibitor provides novel insights into the mechanisms of resistance to Chk1 inhibitorsDNA replication and replicative stress : from fundamental mechanisms to cancer, Dec 2022, Montpellier, France
Poster de conférence
hal-04930325
v1
|
|
|
Purine and pyrimidine biosynthesis inhibitors efficiently suppress equine arteritis virus replication11th International Equine Infectious Diseases Conference, Sep 2021, Online, France. Equine veterinary journal, 53 (S56), pp.64-65, 2021, Special Issue: Abstracts of the 11th International Equine Infectious Diseases Conference. ⟨10.1111/evj.97_13495⟩
Poster de conférence
hal-03374831
v1
|
Development of a nasal drug delivery composite nanosystem for Alzheimer’s desease treatmentJournée normande de recherche biomédicale, Nov 2017, caen, France
Poster de conférence
hal-02295929
v1
|
|
Virtual screening search for HIF-2alpha selective inhibitorsRICT 2016 International conference on medicinal chemistry, 52èmes Rencontres Internationales de Chimie Thérapeutique, Jul 2016, Caen, France
Poster de conférence
hal-02273754
v1
|
2,5-Dimethoxytetrahydrofuran, first updateJohn Wiley & Sons, pp.2012, 2012, 9780471936237. ⟨10.1002/047084289X.rd289.pub2⟩
Ouvrages
(dictionnaire, encyclopédie)
hal-00821463
v1
|
Oxphos inhibitors for use in the treatment of b-cell lymphomaFrance, Patent n° : WO2023194601A1. 2023
Brevet
hal-04946012
v1
|
|
Dérivés du m-Gaïacol, leur préparation et leurs utilisations en tant que biocides, notamment en tant qu’antibactériens ou désinfectants. Brevet Français LABÉO-CERMN (Université de Caen)France, N° de brevet: F073100004/FR/BN, INPI N°1856125. 2018
Brevet
hal-03095627
v1
|
|
Acetylcholinesterase Inhibitor Compounds and 5ht4 Serotonergic Receptor Agonists, with Promnesia Effect, Methods for the Preparation Thereof and Pharmaceutical Compositions Containing SameFrance, Patent n° : WO2014195593 (A2). 2014
Brevet
hal-02042939
v1
|
|
1-Aza-2-alkyl-6-aryl-cycloalkanes usefull as memory enhancersFrance, Patent n° : EP1050530 (A1). 2000
Brevet
hal-02042940
v1
|
Chargement...
Chargement...